DE69941629D1 - Durchsichtige transdermale nicotinabgabevorrichtungen - Google Patents

Durchsichtige transdermale nicotinabgabevorrichtungen

Info

Publication number
DE69941629D1
DE69941629D1 DE69941629T DE69941629T DE69941629D1 DE 69941629 D1 DE69941629 D1 DE 69941629D1 DE 69941629 T DE69941629 T DE 69941629T DE 69941629 T DE69941629 T DE 69941629T DE 69941629 D1 DE69941629 D1 DE 69941629D1
Authority
DE
Germany
Prior art keywords
nicotine
transdermal nicotine
nicotine derivatives
backing layer
transparent transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69941629T
Other languages
English (en)
Inventor
Robert M Gale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27381223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69941629(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DE69941629D1 publication Critical patent/DE69941629D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4465Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26Optical properties
    • A61K2800/262Transparent; Translucent
DE69941629T 1998-12-18 1999-12-14 Durchsichtige transdermale nicotinabgabevorrichtungen Expired - Lifetime DE69941629D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11273098P 1998-12-18 1998-12-18
US12467999P 1999-03-16 1999-03-16
US12679899P 1999-03-30 1999-03-30
PCT/US1999/029731 WO2000037058A1 (en) 1998-12-18 1999-12-14 Transparent transdermal nicotine delivery devices

Publications (1)

Publication Number Publication Date
DE69941629D1 true DE69941629D1 (de) 2009-12-17

Family

ID=27381223

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69941629T Expired - Lifetime DE69941629D1 (de) 1998-12-18 1999-12-14 Durchsichtige transdermale nicotinabgabevorrichtungen

Country Status (23)

Country Link
US (6) US7622136B2 (de)
EP (2) EP2158903A3 (de)
JP (1) JP4864204B2 (de)
KR (1) KR100603168B1 (de)
CN (2) CN101693023A (de)
AT (1) ATE447398T1 (de)
AU (1) AU774594B2 (de)
BR (1) BR9916214A (de)
CA (1) CA2354621C (de)
CY (1) CY1110643T1 (de)
CZ (1) CZ302035B6 (de)
DE (1) DE69941629D1 (de)
DK (1) DK1140039T3 (de)
ES (1) ES2336054T3 (de)
HK (1) HK1040915B (de)
HU (1) HUP0104728A3 (de)
IL (2) IL143778A0 (de)
NO (1) NO332084B1 (de)
NZ (1) NZ512432A (de)
PL (1) PL195871B1 (de)
PT (1) PT1140039E (de)
TR (1) TR200101783T2 (de)
WO (1) WO2000037058A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1140039E (pt) 1998-12-18 2010-02-03 Alza Corp Dispositivos transparentes de administração transdérmica de nicotina
DE10018834A1 (de) * 2000-04-15 2001-10-25 Lohmann Therapie Syst Lts Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
DE10317692A1 (de) 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
DE102005010255A1 (de) * 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
US9056061B2 (en) * 2005-09-23 2015-06-16 Alza Corporation Transdermal nicotine salt delivery system
US8383149B2 (en) * 2005-09-23 2013-02-26 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
EP1774964B1 (de) 2005-10-13 2014-08-06 Nitto Denko Corporation Nikotinhaltiges transdermales therapeutisches System und dessen Herstellung
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
DE102010053792A1 (de) 2010-12-08 2012-06-14 Frank Becher Flächiges wirkstoffhaltiges System zur Entkeimung von Kontaktflächen
DE102011080390B3 (de) * 2011-08-03 2012-07-12 Acino Ag Applikationshilfe
GB2503939A (en) * 2012-07-13 2014-01-15 Kind Consumer Ltd Products derived from tobaccco biomass
WO2015089310A1 (en) * 2013-12-11 2015-06-18 Atkinson Oscar Occlusive skin covering
EP3730128A4 (de) * 2017-12-20 2021-08-04 Easting Biotech Company Limited Klebestruktur
US20220160647A1 (en) * 2020-11-24 2022-05-26 First Necessity, LLC Transdermal drug delivery device/transdermal patch and other applications of emulsion formulation

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US498062A (en) * 1893-05-23 Method of converting iron into steel
US645502A (en) * 1898-10-28 1900-03-13 Lewis A Carpenter Repair-plug for pneumatic tires.
US3797494A (en) 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3731683A (en) 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US4144317A (en) 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
DE2644323C3 (de) * 1976-10-01 1980-03-20 Metallgesellschaft Ag, 6000 Frankfurt Verfahren zum Regenerieren von wasserhaltigen leichtflüchtigen organischen Lösungsmitteln, die zum Auswaschen saurer Gasbestandteile aus wasserarmen Gasen mit geringen Gehalten an flüchtigen Verbindungen von Metallen der 8. Gruppe eingesetzt werden
US4201211A (en) 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
JPS5522535A (en) * 1978-08-04 1980-02-18 Bridgestone Corp Heavy vehicle pneumatic tire
US4203440A (en) 1978-10-23 1980-05-20 Alza Corporation Device having variable volume chamber for dispensing useful agent
JPS5632414A (en) * 1979-08-28 1981-04-01 Suzuki Nihondou:Kk Preparation of stretchable clear sticking plaster
US4286592A (en) 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4314557A (en) 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
JPS6244654Y2 (de) * 1981-04-11 1987-11-26
US4849226A (en) 1981-06-29 1989-07-18 Alza Corporation Method for increasing oxygen supply by administering vasodilator
US4725272A (en) 1981-06-29 1988-02-16 Alza Corporation Novel bandage for administering beneficial drug
US4373454A (en) 1981-08-28 1983-02-15 The United States Of America As Represented By The Department Of Energy Oil shale retorting and combustion system
US4435180A (en) 1982-05-25 1984-03-06 Alza Corporation Elastomeric active agent delivery system and method of use
US4559222A (en) 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
JPS6069014A (ja) 1983-09-27 1985-04-19 Nitto Electric Ind Co Ltd 皮膚疾患治療用貼付剤
US4627850A (en) 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
AU591171B2 (en) 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
US4704282A (en) 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
EP0177329B1 (de) 1984-10-05 1992-09-30 Hercon Laboratories Corporation System zur transdermalen Applikation eines Arzneimittels
US4568343A (en) 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4573995A (en) 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
DE3586713T2 (de) 1984-11-15 1993-05-13 Hercon Lab Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
US4597961A (en) 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
US5016652A (en) 1985-04-25 1991-05-21 The Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4904475A (en) 1985-05-03 1990-02-27 Alza Corporation Transdermal delivery of drugs from an aqueous reservoir
US4645502A (en) 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4698062A (en) 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4710191A (en) 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
US5316759A (en) 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
ES2028074T3 (es) 1986-06-13 1992-07-01 Alza Corporation Activacion por humedad de un sistema de suministro transdermico de farmacos.
US4938759A (en) 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US4908027A (en) 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US5344656A (en) 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4816258A (en) 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
US4788062A (en) 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US5071656A (en) 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
IL86170A (en) 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
DE3743947A1 (de) 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur gesteuerten abgabe von nicotin, verfahren zu ihrer herstellung sowie ihre verwendung
US4943435A (en) 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US4839174A (en) 1987-10-05 1989-06-13 Pharmetrix Corporation Novel transdermal nicotine patch
US4917895A (en) 1987-11-02 1990-04-17 Alza Corporation Transdermal drug delivery device
US4781924A (en) 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4915895A (en) * 1987-11-30 1990-04-10 General Motors Corporation Method for making a composite tread for track-laying vehicles
US4915950A (en) 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US4840796A (en) 1988-04-22 1989-06-20 Dow Corning Corporation Block copolymer matrix for transdermal drug release
US5004610A (en) 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5364630A (en) 1988-06-14 1994-11-15 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5167649A (en) 1988-08-22 1992-12-01 Zook Gerald P Drug delivery system for the removal of dermal lesions
US4908213A (en) 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
US5230896A (en) 1989-10-12 1993-07-27 Warner-Lambert Company Transdermal nicotine delivery system
US5077104A (en) 1989-12-21 1991-12-31 Alza Corporation Nicotine packaging materials
SE8904296D0 (sv) 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
US5324280A (en) 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5508038A (en) 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
US5122382A (en) 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5314694A (en) 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
JP3067114B2 (ja) * 1991-06-04 2000-07-17 ソニー株式会社 マイクロレンズ形成方法
JPH0523925A (ja) 1991-07-19 1993-02-02 Mazda Motor Corp 部品組付装置におけるフローテイング支持機構
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US6010715A (en) 1992-04-01 2000-01-04 Bertek, Inc. Transdermal patch incorporating a polymer film incorporated with an active agent
WO1993023025A1 (en) 1992-05-13 1993-11-25 Alza Corporation Transdermal administration of oxybutynin
US5264219A (en) * 1992-08-07 1993-11-23 Minnesota Mining And Manufacturing Company Transdermal drug delivery backing
AU7323794A (en) 1993-07-09 1995-02-06 Cygnus Therapeutic Systems Method and device for providing nicotine replacement therapy transdermally/transbuccally
US5362496A (en) 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
JPH07165563A (ja) * 1993-12-08 1995-06-27 Sekisui Chem Co Ltd テープ製剤
AU676430B2 (en) 1994-03-07 1997-03-06 Theratech, Inc. Drug-containing adhesive composite transdermal delivery device
AU2703795A (en) 1994-06-23 1996-01-19 Procter & Gamble Company, The Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
WO1997033581A1 (en) 1996-03-13 1997-09-18 Yale University Smoking cessation treatments using naltrexone and related compounds
CA2250025C (en) 1996-03-25 2006-10-31 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic system with small application-area thickness and great flexibility, and production process
JPH09323925A (ja) * 1996-06-03 1997-12-16 Sekisui Chem Co Ltd 貼付剤
GR1002807B (el) * 1996-06-20 1997-11-13 Lavipharm A.E. Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
US6512010B1 (en) 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
IT1289160B1 (it) 1997-01-08 1998-09-29 Jagotec Ag Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
US6203817B1 (en) 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
JPH10279472A (ja) * 1997-04-02 1998-10-20 Oji Paper Co Ltd 外用貼付剤
JP2001517493A (ja) * 1997-09-26 2001-10-09 ノーヴェン ファーマシューティカルズ インコーポレイテッド 生体接着剤組成物及び活性薬剤の局所投与方法
US6013722A (en) 1998-01-27 2000-01-11 3M Innovative Properties Company Non-whitening emulsion pressure sensitive adhesives
FR2778560B1 (fr) * 1998-05-12 2001-06-01 Oreal Utilisation de l'acide cinnamique ou d'au moins l'un de ses derives dans une composition destinee a favoriser la desquamation de la peau, et composition le comprenant
PT1140039E (pt) 1998-12-18 2010-02-03 Alza Corp Dispositivos transparentes de administração transdérmica de nicotina
CN102736278B (zh) 2011-04-01 2014-12-17 纬创资通股份有限公司 液晶显示装置及具有该液晶显示装置的电子设备

Also Published As

Publication number Publication date
KR20010084881A (ko) 2001-09-06
HUP0104728A3 (en) 2006-07-28
HK1040915B (zh) 2010-05-07
EP1140039A1 (de) 2001-10-10
US7622136B2 (en) 2009-11-24
AU3121700A (en) 2000-07-12
AU774594B2 (en) 2004-07-01
EP2158903A2 (de) 2010-03-03
NO332084B1 (no) 2012-06-18
ES2336054T3 (es) 2010-04-07
CN1331586A (zh) 2002-01-16
HK1040915A1 (en) 2002-06-28
US20040234585A1 (en) 2004-11-25
KR100603168B1 (ko) 2006-07-24
TR200101783T2 (tr) 2002-05-21
CA2354621C (en) 2009-09-29
WO2000037058A1 (en) 2000-06-29
DK1140039T3 (da) 2010-03-22
PT1140039E (pt) 2010-02-03
CY1110643T1 (el) 2015-04-29
IL143778A (en) 2008-03-20
NZ512432A (en) 2003-10-31
US20080031933A1 (en) 2008-02-07
ATE447398T1 (de) 2009-11-15
JP4864204B2 (ja) 2012-02-01
US20140180223A1 (en) 2014-06-26
IL143778A0 (en) 2002-04-21
US8663680B2 (en) 2014-03-04
US8999379B2 (en) 2015-04-07
US20120310187A1 (en) 2012-12-06
CA2354621A1 (en) 2000-06-29
CN101693023A (zh) 2010-04-14
HUP0104728A2 (hu) 2002-05-29
US20160058747A1 (en) 2016-03-03
JP2002532540A (ja) 2002-10-02
US20150164820A1 (en) 2015-06-18
CZ20012230A3 (cs) 2001-10-17
BR9916214A (pt) 2001-09-11
CZ302035B6 (cs) 2010-09-15
EP1140039B1 (de) 2009-11-04
US9205059B2 (en) 2015-12-08
NO20013012D0 (no) 2001-06-18
US8075911B2 (en) 2011-12-13
PL348337A1 (en) 2002-05-20
EP2158903A3 (de) 2010-04-14
NO20013012L (no) 2001-06-18
PL195871B1 (pl) 2007-11-30

Similar Documents

Publication Publication Date Title
DE69941629D1 (de) Durchsichtige transdermale nicotinabgabevorrichtungen
FI882417A (fi) Transdermaalinen järjestelmä, sen valmistusmenetelmä ja käyttö
YU226090A (sh) Postupak za izradu transdermalnog terapijskog sistema sa buprenorphinom kao aktivnim sastojkom
DK581685A (da) Transderimalt system for timolol-indgift
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
BR9607212A (pt) Uso de uma nsaid-r em uma composição de proteção para o tratamento de cancer de colo retal
YU48102B (sh) Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen
NO895172D0 (no) Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med phytostigmin som virkestoff.
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
NZ332215A (en) Transdermally administered dextromethorphan as antitussive agent
ES2131122T3 (es) Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina.
NO993841L (no) Blandinger og anordninger for redusering av virkningene av inflammasjon
NO895173D0 (no) Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med norpseudoefedrin som virkestoff.
DE59009378D1 (de) Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung.
YU71293A (sh) Transdermalni terapijski sistem za davanje fizostigmina na koži i postupak za njegovu izradu

Legal Events

Date Code Title Description
8363 Opposition against the patent